What is Neuropace, Inc.'s retained earnings?

Neuropace, Inc. (NPCE) reported retained earnings of -$559.1M in Q1 2026.

How has Neuropace, Inc.'s retained earnings changed year-over-year?

Neuropace, Inc.'s retained earnings decreased by 4.0% year-over-year, from -$537.54M to -$559.1M.

What is the long-term trend for Neuropace, Inc.'s retained earnings?

Over 5 years (2020 to 2025), Neuropace, Inc.'s retained earnings has grown at a 7.3% compound annual growth rate (CAGR), from -$387.69M to -$552.42M.

What does retained earnings mean?

Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.

Neuropace, Inc. NPCE Retained Earnings

Retained Earnings at other companies

MedtronicMDT

$32.64B+3.7%

LivaNovaLIVN

-$1.12B+8.7%

ClearPoint NeuroCLPT

-$226.46M-14.7%

Inspire Medical SystemsINSP

-$157.79M+45.4%

Orthofix Medical Inc.OFIX

-$389.24M-18.2%

ARS Pharmaceuticals, Inc.SPRY

-$355.22M-126%

Other financials

Income statement

See full

Revenue$22.1M-2.0%

Gross profit$18.0M+4.1%

Operating income-$5.6M-8.2%

Net income-$6.7M-1.5%

EPS (diluted)-$0.20+4.8%

Balance sheet

See full

Cash & equivalents$15.6M-42.4%

Total debt$70.5M-3.7%

Total equity$14.5M-40.4%

Total assets$98.9M-10.3%

Cash flow

See full

Operating cash flow-$5.9M+21.1%

CapEx$117.0K+216%

Free cash flow-$6.0M+20.0%

Valuation

See full

Market cap$557.77M+63.4%

Enterprise value$612.6M+58.1%

P/S5.6×+1.6×

Profitability

See full

Gross margin78.3%+3.5pp

Operating margin-16.8%-3.5pp

Net margin-21.7%-4.5pp

FCF margin-10.3%-3.5pp

Returns & leverage

See full

Return on equity-111.4%-13.1pp

Debt / equity4.9×+1.9×

Current ratio5.4×-1.2×

Where this comes from

Reported directly by Neuropace, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuropace, Inc.'s retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Neuropace, Inc.'s retained earnings?: Neuropace, Inc. (NPCE) reported retained earnings of -$559.1M in Q1 2026.
How has Neuropace, Inc.'s retained earnings changed year-over-year?: Neuropace, Inc.'s retained earnings decreased by 4.0% year-over-year, from -$537.54M to -$559.1M.
What is the long-term trend for Neuropace, Inc.'s retained earnings?: Over 5 years (2020 to 2025), Neuropace, Inc.'s retained earnings has grown at a 7.3% compound annual growth rate (CAGR), from -$387.69M to -$552.42M.
What does retained earnings mean?: Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.